AC
Acrivon Therapeutics, Inc. Common Stock (ACRV)
NASDAQ·Healthcare·Biotechnology
$1.89
+0.53%
Mkt Cap $59.33M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $166.29K | — | — | -$0.49 | -$0.49 | +0.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.57 | -$0.47 | +17.54% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.57 | -$0.55 | +3.51% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.57 | -$0.51 | +10.53% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.69 | -$0.60 | +13.04% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.56 | -$0.59 | -5.36% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.59 | -$0.52 | +11.86% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.89 | -$0.73 | +17.98% | — | — |
| Q1 2024 Mar 28, 2024 | — | $1.88M | — | -$0.72 | -$0.86 | -19.44% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.72 | -$0.66 | +8.33% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$0.68 | -$0.63 | +7.35% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.60 | -$0.58 | +3.33% | — | — |
| Q1 2023 Mar 28, 2023 | — | — | — | -$1.09 | -$0.80 | +26.61% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$2.44 | -$0.47 | +80.78% | — | — |
| Q3 2022 Aug 14, 2022 | — | — | — | — | -$0.44 | — | — | — |
| Q2 2022 May 15, 2022 | — | — | — | — | -$0.56 | — | — | — |
| Q1 2022 Feb 14, 2022 | — | — | — | — | -$0.17 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.34 | — | — | — |